Lui GYL

ORCID: 0000-0003-2741-6025 · 1 paper in corpus

2021

Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT Inhibition as a Therapeutic Strategy for Ovarian Clear Cell Carcinoma.

Molecular cancer therapeutics ·doi:10.1158/1535-7163.mct-20-0809

Ovarian clear cell carcinoma (OCCC) is a rare, chemo-resistant subtype of ovarian cancer. To identify novel therapeutic targets and combination therapies for OCCC, we subjected a set of patient-derived ovarian cancer cell lines to arrayed h…